Paid Clinical Trials Joliet
Discover 2,270 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
TebapivatA Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Sponsor:
Agios Pharmaceuticals, Inc.
Location:
Code:
NCT05490446
Conditions
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tebapivat
ASP2138 with Cancer TreatmentsA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Sponsor:
Astellas Pharma Global Development, Inc.
Location:
Code:
NCT05365581
Conditions
Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ASP2138
Pembrolizumab
Oxaliplatin
Leucovorin
Fluorouracil
Preconception CarePromoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
Sponsor:
Northwestern University
Location:
Code:
NCT04976881
Conditions
Diabetes Mellitus, Type 2
Electronic Health Record
Primary Health Care
Reproductive Behavior
Eligibility Criteria
Sex: Female
Age: 18 - 44
Healthy Volunteers: Not accepted
Interventions
Medication Reconciliation (MedRec) Tool
Provider Alert and Decision Support
PREPSheet
Text Messaging
IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT04557462
Conditions
Primary IgA Nephropathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
LNP023
Virco®TYPE HIV-1 vs. Expert InterpretationA Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Sponsor:
Ruth M. Rothstein CORE Center
Location:
Code:
NCT00840762
Conditions
HIV-1
HIV Infections
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
VircoType HIV-1 genotypic interpretation
Local Expert Review of HIV Genotypic resistance testing
LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06074562
Conditions
Diabetic Peripheral Neuropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3556050
Placebo
Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
Sponsor:
Arog Pharmaceuticals, Inc.
Location:
Code:
NCT03258931
Conditions
Newly Diagnosed FLT3 Mutated AML
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Crenolanib
Midostaurin
Cytarabine
Duanorubicin
Observational StudyContinuous Monitoring and Control of Hypoglycemia
Sponsor:
DexCom, Inc.
Location:
Code:
NCT03340831
Conditions
Diabetes
Eligibility Criteria
Sex: All
Age: 2+
Healthy Volunteers: Not accepted
Interventions
Continuous Glucose Monitoring (CGM)
Neoadjuvant ChemotherapyEvaluating the Response to Neoadjuvant Chemotherapy With Circulating Tumor DNA in Pancreatic Cancer
Sponsor:
Central DuPage Hospital
Location:
Code:
NCT04616131
Conditions
Pancreas Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
BrioVADInvestigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Sponsor:
BrioHealth Solutions, Inc.
Location:
Code:
NCT06310031
Conditions
Cardiovascular Diseases
Heart Diseases
Heart Failure
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BrioVAD System
HeartMate 3